nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—PDE3A—penis—rectum cancer	0.691	0.691	CbGeAlD
Anagrelide—PDE3A—smooth muscle tissue—rectum cancer	0.117	0.117	CbGeAlD
Anagrelide—PDE3A—female reproductive system—rectum cancer	0.0901	0.0901	CbGeAlD
Anagrelide—PDE3A—lymph node—rectum cancer	0.0527	0.0527	CbGeAlD
Anagrelide—CYP1A2—renal system—rectum cancer	0.0498	0.0498	CbGeAlD
